Skip to content

Programme – Seminar 1

EAHP Academy Seminar 2019

An ACPE application based activity

ACPE Universal Activity Number (UAN): 0475-0000-19-038-L04-P/CEUs: 1.3

“Seminar 1: Antibiotic Stewardship: Advanced”

FRIDAY, 20 SEPTEMBER 2019, DIAMOND ROOM

08.00 – 08.05

Invitational speech by the President of the European Association of Hospital Pharmacists
Pharm Dr Petr Horák, President of the EAHP, Czech Republic

08.05 – 08.20               

Welcome – Needs and Objectives of the Academy Seminar
Dr Kornelia Chrapkova, Institute for Clinical and Experimental Medicine, Prague, Czech Republic, EAHP Member of the Scientific Committee (facilitator)

08.20 – 08.30

Assessment of Learning success – SurveyMonkey®  (Part-1 – pre-meeting baseline)
Delegates

08.30 – 09.15                  

Therapeutic drug monitoring for all drugs and for all patients?
Dr Ute BlassmannHeidelberg University Hospital, Germany

09.15 – 10.00 

Do we need therapeutic drug monitoring for beta lactams or can we just use prolonged infusions?
Dr Ute Blassmann, Heidelberg University Hospital, Germany

10.00 – 10.30

Coffee break (Sky Lounge)

10.30 – 11.15

The impact of PK/PD for clinical decisions 
Dr Anouk Muller, HaaglandenMC, The Hague and ErasmusMC, Rotterdam 

11.15 – 12.00

MIC directed therapy: why, when and what are the pitfalls?
Dr Anouk Muller, HaaglandenMC, The Hague and ErasmusMC, Rotterdam

12.00 – 13.30

Lunch break (Restaurant Catharina)

13.30 – 15.00

Interactive Part – clinical cases – PK/PD
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Dr Peter Declercq, University Hospitals Leuven, Belgium

  • Case studies
  • Monitoring
  • PK/PD
 15.00 – 15.30

Coffee break (Sky Lounge)

15.30 – 17.00

Implementation of check of medication appropriateness: what can the computer do for ABS?
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Tine Van Nieuwenhuyse, UZ Leuven, Belgium 

17.00 – 17.30

Summary of Day 1

19.30 – 22.30

Dinner at the hotel (Restaurant Catharina)

   

SATURDAY, 21 SEPTEMBER 2019, DIAMOND ROOM

08.00 – 09.15

Antifungal therapy: what comes out of the pipeline in the near future?
Prof William Hope*University of Liverpool, United Kingdom

09.15 – 10.00

TDM and PK/PD in antifungal therapy: when and why?
Prof William Hope*, University of Liverpool, United Kingdom

10.00 – 10.30

Coffee break (Sky Lounge)

10.30 – 11.15

Antimicrobial prophylaxis in HSCT-patients: guidelines and evidence
Dr Philipp Wohlfarth, Medical University of Vienna, Austria

  • Antibiotics
  • Antifungals
  • Antivirals

11.15 – 12.00     

Hygiene measures, isolation and therapy
Prof Dr Annette Schuermans, University Hospitals Leuven, Belgium

12.00 – 13.30

Lunch break (Restaurant Catharina)

13.30 – 14.30

What’s really new in antibiotic therapy
Prof Dr Martin J. Hug, Institute of Pharmaceutical Sciences, University of Freiburg, Germany

  • new drugs in the pipeline,
  • new therapeutic principles like bacteriophages
  • fecal transplantation
14.30 – 15.00  Coffee break (Sky Lounge)

15.00 – 16.30

Interactive Part
Prof Dr Isabel Spriet, UZ Leuven, Belgium
Prof William Hope*, University of Liverpool, United Kingdom

  • Case studies – focus on antifungal therapy (PK/PD. guidelines)

16.30 – 16.45

Assessment of Learning success – SurveyMonkey® (Part 2 – post-meeting assessment)
Delegates

16.45 – 17.00

Summary and closing remarks
Dr Kornelia Chrapkova, Institute for Clinical and Experimental Medicine, Prague, Czech Republic
Dr Inese Sviestina, Children Clinical University Hospital / University of Latvia, Riga, Latvia, EAHP Member of the Scientific Committee (facilitator)

17.00 – 17.05

Closing speech by the President of the National Association of Hospital Pharmacists from Belgium
Prof Dr Thomas De Rijdt, Chairman of EAHP Scientific Committee

18.20

Meet in the hotel lobby

18.40

Departure by bus from the hotel

19.30 – 22.30

Dinner at the restaurant Skievelat De Wand

23.00 Return to the hotel
 


SUNDAY, 22 SEPTEMBER 2019

08.15

Meet in the hotel lobby

08:30 – 11.30

City Tour. Departure by bus from the hotel. 

12.30

Return to the hotel


Important note:
 EAHP confirms that the Speakers and the Scientific Committee members responsible for the development of the Academy Seminar programme have signed and submitted the Conflict of Interest Disclosure forms.

* Indicates speaker or SC member has stated a conflict of interest.

EAHP will cover the expenses of the seminar registration, hotel accommodations for three nights (19 – 20 – 21 September), as well as, official meals. Travel expenses have to be covered by the participant or your organisation.

The European Association of Hospital Pharmacists (EAHP) is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharamacy education.

×

EAHP Forum

All the EAHP team is working on providing a Forum that can help connect all the members in Conversations and Groups to talk about important matters for the European Hospital Pharmacist.

The Forum will be accessible for all the EAHP members, you don’t have to create a new account to browse and participate.

Conversations and groups

The Conversations will be moderated by our team to provide documents and relevant topics for the community.

The Groups will connect all members that share a category. Members who work on the same assocation, on the same hospital, that have the same role, etc.

Stay tuned for the realase of the forum. Soon on EAHP.